Daniel Paul Regan Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Daniel Paul Regan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Daniel Paul Regan. Daniel Paul Regan is Chief Commercial Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT).
Latest Insider Trading Transactions of Daniel Paul Regan
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Option Exercise | M | 37.69 | 20,000 | 753,800 | 110,000 | |
Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 442.49 | 300 | 132,747 | 0 | 300 to 0 (-100.00 %) |
Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 441.60 | 1,288 | 568,774 | 300 | 1.6 K to 300 (-81.11 %) |
Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 440.63 | 812 | 357,791 | 1,588 | 2.4 K to 1.6 K (-33.83 %) |
Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 439.94 | 502 | 220,849 | 2,400 | 2.9 K to 2.4 K (-17.30 %) |
Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 438.45 | 898 | 393,732 | 2,902 | 3.8 K to 2.9 K (-23.63 %) |
Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 436.77 | 1,960 | 856,077 | 3,800 | 5.8 K to 3.8 K (-34.03 %) |
Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 435.70 | 1,140 | 496,701 | 5,760 | 6.9 K to 5.8 K (-16.52 %) |
Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 434.57 | 1,949 | 846,975 | 6,900 | 8.8 K to 6.9 K (-22.03 %) |
Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 433.47 | 7,027 | 3,046,012 | 8,849 | 15.9 K to 8.8 K (-44.26 %) |
Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 432.84 | 1,724 | 746,218 | 15,876 | 17.6 K to 15.9 K (-9.80 %) |
Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 431.34 | 339 | 146,223 | 17,600 | 17.9 K to 17.6 K (-1.89 %) |
Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 429.96 | 361 | 155,214 | 17,939 | 18.3 K to 17.9 K (-1.97 %) |
Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 428.51 | 700 | 299,956 | 18,300 | 19 K to 18.3 K (-3.68 %) |
Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 427.05 | 500 | 213,524 | 19,000 | 19.5 K to 19 K (-2.56 %) |
Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 426.06 | 500 | 213,028 | 19,500 | 20 K to 19.5 K (-2.50 %) |
Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Buy | M | 37.69 | 20,000 | 753,800 | 20,000 | 0 to 20 K |
Page: 1